Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of 177Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol

By afschroeder • August 29, 2025

Holzgreve A, Delker A, Ells Z, Brosch-Lenz J, Unterrainer LM, Nikitas J, Zhu S, Contreras MM, Alam H, Nabong RM, Lira S, Vasilyev A, Chen L, Grogan T, Elashoff D, Meyer CA, Dahlbom M, Czernin J, Calais J. Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of ¹⁷⁷Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol. J Nucl Med. 2025 Aug 28:jnumed.125.269495. doi: 10.2967/jnumed.125.269495. Epub ahead of print. PMID: 40876952.

Tags: [177Lu]Lu-PSMA-617, DOM STAT, General Internal Medicine, mCRPC, metastatic castration-resistant prostate cancer, Primary Care, prostate-specific membrane antigen, PSMA, Publications, radiopharmaceutical therapy, RPT, SPECT/CT, therapy response assessment, treatment holidays

Donna L. Washington, MD, MPH, FACP Appointed Section Chief of General Internal Medicine at the VA Greater Los Angeles Healthcare System

It is with great pleasure that we announce the appointment of Donna L. Washington, MD, MPH, FACP as the incoming section chief of General Internal Medicine at[...]

Effect of Language Interpreter Modalities on Patient Satisfaction and Clinical Workflow: A Pilot Study in a Multidisciplinary Pediatric Craniofacial Clinic

Juang S, Nguyen S, Osman N, Ghodrati K, Reyes C, Maldonado I, Pino J, Duarte M, Halley K, Hendrickson I, Tu M, Peralta JB, Wilhalme[...]

Reframing Opioid Overdose as an Ambulatory Care-Sensitive Condition

Hsu M, Lawrence D, Capone-Newton P, Gelberg L. Reframing Opioid Overdose as an Ambulatory Care-Sensitive Condition. JAMA. 2025 Dec 29. doi: 10.1001/jama.2025.23741. Epub ahead of[...]